Search hospitals > New York > Garden City
Accumed Research Associates
Claim this profileGarden City, New York 11530
Global Leader in Prostate Cancer
Conducts research for Low Testosterone
Conducts research for Overactive Bladder
Conducts research for Urinary Incontinence
Conducts research for Bedwetting
68 reported clinical trials
1 medical researcher
Summary
Accumed Research Associates is a medical facility located in Garden City, New York. This center is recognized for care of Prostate Cancer, Low Testosterone, Overactive Bladder, Urinary Incontinence, Bedwetting and other specialties. Accumed Research Associates is involved with conducting 68 clinical trials across 61 conditions. There are 1 research doctors associated with this hospital, such as Mitchell Efros, MD.Top PIs
Clinical Trials running at Accumed Research Associates
Bladder Cancer
Interstitial Cystitis
Somatoform Disorders
Syndrome
Bladder Infection
Low Testosterone
Cancer
Transitional Cell Carcinoma
Urinary Tract Infection
E. coli Infections
UGN-103
for Bladder Cancer
This Phase 3, single-arm, multicenter study will evaluate the efficacy and safety of UGN-103, a novel formulation of UGN-102, instilled in the urinary bladder of patients with low-grade non-muscle invasive bladder cancer (LG-NMIBC).
Recruiting2 awards Phase 32 criteria
TARA-002
for Bladder Cancer
TARA-002-101-Ph2 is an open-label study to investigate the safety and anti-tumor activity of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1). The purpose of this Phase 2 study (TARA-002-101-Ph2) is to further assess the safety and anti-tumor activity of TARA-002 at the RP2D which has been established in the Phase 1a dose finding study (TARA-002-101-Ph1a). This Phase 2 study includes participants with CIS NMIBC (± Ta/T1) with active disease (defined as disease present at last tumor evaluation prior to signing ICF). Participants will be enrolled into one of 2 cohorts: Cohort A: * Participants with CIS (± Ta/T1) who are BCG naive, or * Participants with CIS (± Ta/T1) who are BCG exposed and have not received intravesical BCG for at least 24 months prior to the most recent CIS diagnosis Cohort B: * Participants with persistent or recurrent CIS (± Ta/T1) who are BCG unresponsive within 12 months of completion of adequate BCG therapy (minimum 5/6 doses induction and 2/3 doses maintenance or 2/6 doses reinduction)
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Accumed Research Associates?
Accumed Research Associates is a medical facility located in Garden City, New York. This center is recognized for care of Prostate Cancer, Low Testosterone, Overactive Bladder, Urinary Incontinence, Bedwetting and other specialties. Accumed Research Associates is involved with conducting 68 clinical trials across 61 conditions. There are 1 research doctors associated with this hospital, such as Mitchell Efros, MD.